Pyxis Oncology, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
PYXS chart
What traders are saying about $PYXS
Latest postsPyxis Oncology, Inc. news
- Form 4 Pyxis Oncology Inc: Rachel Humphrey (Director) For: 6 November
Investing.com Nigeria ·
- Pyxis Oncology, Inc. (PYXS) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- 34,500 options granted by Pyxis Oncology (PYXS) to Rachel Humphrey carry a $1.66 exercise price.
Stock Titan ·
- Pyxis Oncology Stock Price Forecast. Should You Buy PYXS?
StockInvest.us ·
- RBC Capital maintains Pyxis Oncology at Outperform, raises price target to $7 from $6
TradingView ·
- Pyxis Oncology, Inc. (PYXS) Seasonal returns chart
Yahoo Finance UK ·
- Wedbush maintains Pyxis Oncology at Outperform, lowers price target to $7 from $8
TradingView ·
- Pyxis Oncology Catalysts on Track With Upcoming Trial Results in Head, Neck Cancer Treatment, RBC Says
Yahoo Finance ·
- Stifel Maintains Pyxis Oncology(PYXS.US) With Buy Rating, Cuts Target Price to $5
Moomoo ·
- Stifel cuts Pyxis Oncology stock price target to $5 on financing
Investing.com Canada ·
- Pyxis Oncology Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Wedbush Adjusts Price Target on Pyxis Oncology to $7 From $8, Keeps Outperform Rating
marketscreener.com ·
Pyxis Oncology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $13.9M | $16.1M | – | – |
| Net income | -$79.6M | -$77.3M | -$73.8M | -$120.7M |
| Diluted EPS | $-1.28 | $-1.32 | $-1.85 | $-3.65 |
| Total assets (year end) | $91.5M | $157.2M | $173.7M | $211.4M |
| Cash and equivalents (year end) | $15.4M | $19.5M | $9.7M | $179.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Pyxis Oncology, Inc.
- Ticker
- PYXS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1782223
Frequently asked questions
What exchange is Pyxis Oncology, Inc. listed on?
Pyxis Oncology, Inc. trades on the Nasdaq under the ticker symbol PYXS.
What industry is Pyxis Oncology, Inc. in?
Pyxis Oncology, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Pyxis Oncology, Inc. headquartered?
Pyxis Oncology, Inc.'s business address on file with the SEC is in Boston, MA.
When does Pyxis Oncology, Inc.'s fiscal year end?
Pyxis Oncology, Inc.'s fiscal year ends on December 31.
How much revenue did Pyxis Oncology, Inc. report?
Pyxis Oncology, Inc. reported $13.9M in revenue for calendar year 2025, according to its SEC filings.